DRs Not Prescribing Abortion Pill

Article

WASHINGTON, DC-Surrounded by controversy years before becoming legal in the US one year ago, RU-486 was designed as a non-surgical abortion option. However, a new survey from the nonprofit Kasier Family Foundation reports 6% of American gynecologists are providing the prescription.

While Planned Parenthood clinics and abortions clinics nationally offer the medication, many surveyed gynecologists say they do not offer the pill, known as mifepristone, or Mifeprex, because they personally oppose abortion. The pill is prescribed by only a small percentage of the 27% of the gynecologists who perform surgical abortions.

A different Kaiser survey showed also that women are not informed about the option. Of 1,000 women surveyed, 42% thought RU-486 was the "morning-after pill." The morning-after pill is actually a high dose of birth control pills taken the morning after an unprotected sexual encounter. This prescription is not considered abortion because the sperm is kept from fertilizing the egg. The morning-after pill can be taken up to 72 hours after having unprotected sex.

RU-486 is for women who want to end a pregnancy without surgery. The pill can be taken up to seven weeks after the beginning of the last menstrual period.

Information from www.latimes.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.